Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

• Status: Unknown status
• Trial end date: 2005-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Treatments: Aripiprazole; Methamphetamine

Criteria

Inclusion Criteria:

• Must meet DSM-4 criteria for methamphetamine abuse or dependence and are non-treatment seeking.

• Ability to verbalize understanding of the consent form, able to provide written informed consent, and verbalize willingness to complete study procedures.

Exclusion Criteria:

• Please contact the site for more information.